Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
J&J Settlement Leaves Teva As Sole Opioid Maker In Bellwether Trial
Oct 02 2019
•
By
Brenda Sandburg
J&J is fourth opioid manufacturer to settle out of the bellwether trial in Ohio
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Legal & IP
More from Pink Sheet